FGL1 and metabolic dysfunction-associated steatotic liver disease: High levels of HPS in patients with NAFLD.Increased expression of HPS causes upregulation of lipogenic proteins, ultimately leading to an increase in the accumulation of hepatic triglycerides (TGs).Upregulation of HPS stimulates inflammatory cytokines and liver injury.